Last chance to save on Digiday Publishing Summit passes is February 9
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Here’s what else a $8M, 30-second Super Bowl budget can purchase in 2026
Digiday once again takes a look at what $8 million can afford a buyer elsewhere elsewhere in the media landscape.
ICE has become a national issue for Target
More groups and activists outside of Minnesota have also been calling out Target’s relative silence on ICE activity in its home state.
WTF is Google’s Universal Commerce Protocol?
Google launched its UCP last month — a foundational layer which looks to enable agentic shopping within the tech giant’s ecosystem.